Hersant Barbara, Sid-Ahmed Mounia, Braud Laura, Jourdan Maud, Baba-Amer Yasmine, Meningaud Jean-Paul, Rodriguez Anne-Marie
Université Paris-Est, UMR-S955, UPEC, Créteil, France.
INSERM U955, Créteil, France.
Stem Cells Int. 2019 Oct 31;2019:1234263. doi: 10.1155/2019/1234263. eCollection 2019.
Chronic and acute nonhealing wounds represent a major public health problem, and replacement of cutaneous lesions by the newly regenerated skin is challenging. Mesenchymal stem cells (MSC) and platelet-rich plasma (PRP) were separately tested in the attempt to regenerate the lost skin. However, these treatments often remained inefficient to achieve complete wound healing. Additional studies suggested that PRP could be used in combination with MSC to improve the cell therapy efficacy for tissue repair. However, systematic studies related to the effects of PRP on MSC properties and their ability to rebuild skin barrier are lacking. We evaluated in a mouse exhibiting 4 full-thickness wounds, the skin repair ability of a treatment combining human adipose-derived MSC and human PRP by comparison to treatment with saline solution, PRP alone, or MSC alone. Wound healing in these animals was measured at day 3, day 7, and day 10. In addition, we examined in vitro and in vivo whether PRP alters in MSC their proangiogenic properties, their survival, and their proliferation. We showed that PRP improved the efficacy of engrafted MSC to replace lost skin in mice by accelerating the wound healing processes and ameliorating the elasticity of the newly regenerated skin. In addition, we found that PRP treatment stimulated , in a dose-dependent manner, the proangiogenic potential of MSC through enhanced secretion of soluble factors like VEGF and SDF-1. Moreover, PRP treatment ameliorated the survival and activated the proliferation of cultured MSC and that these effects were accompanied by an alteration of the MSC energetic metabolism including oxygen consumption rate and mitochondrial ATP production. Similar observations were found following combined administration of PRP and MSC into mouse wounds. In conclusion, our study strengthens that the use of PRP in combination with MSC might be a safe alternative to aid wound healing.
慢性和急性难愈合伤口是一个重大的公共卫生问题,用新再生的皮肤替代皮肤损伤具有挑战性。为了再生缺失的皮肤,分别对间充质干细胞(MSC)和富血小板血浆(PRP)进行了测试。然而,这些治疗往往仍无法有效实现完全伤口愈合。更多研究表明,PRP可与MSC联合使用,以提高细胞治疗对组织修复的疗效。然而,缺乏与PRP对MSC特性及其重建皮肤屏障能力影响相关的系统性研究。我们在一只出现4处全层伤口的小鼠中,评估了将人脂肪来源的MSC与人类PRP联合治疗与生理盐水、单独使用PRP或单独使用MSC治疗相比的皮肤修复能力。在第3天、第7天和第10天测量这些动物的伤口愈合情况。此外,我们在体外和体内研究了PRP是否会改变MSC的促血管生成特性、存活率和增殖能力。我们发现,PRP通过加速伤口愈合过程和改善新再生皮肤的弹性,提高了移植的MSC替代小鼠缺失皮肤的疗效。此外,我们发现PRP治疗以剂量依赖的方式,通过增强VEGF和SDF-1等可溶性因子的分泌,刺激了MSC的促血管生成潜力。此外,PRP治疗改善了培养的MSC的存活率并激活了其增殖,并且这些作用伴随着MSC能量代谢的改变,包括耗氧率和线粒体ATP生成。在将PRP和MSC联合注入小鼠伤口后也发现了类似的观察结果。总之,我们的研究强化了PRP与MSC联合使用可能是促进伤口愈合的一种安全替代方法的观点。